Clinical Study

Clinical Characteristics and Surgical Prognosis of Hepatocellular Carcinoma with Bile Duct Invasion

Table 1

Preoperative clinical variables of HCC patients with and without bile duct invasion.

Clinical parametersBile duct invasion value
Yes ( )No ( )
Number or mean% or SENumber or mean% or SE

Age (y)51.32.050.20.60.571
Gender
 Male/female24/1168.6/31.4309/6981.7/18.30.073
Virus status
 HBV/HCV/none26/0/974.3/0/25.7286/7/8575.7/1.9/22.50.669
Child-Pugh classification
 A/B25/1071.4/28.6276/10273.0/27.00.839
Liver cirrhosis2571.424765.30.577
Hemoglobin (g/L)130.54.9128.81.70.752
Platelet count (×109/L)122.16.6113.93.20.439
TBIL (umol/L)54.019.022.51.7<0.001
ALT (U/L)83.922.962.53.40.102
AST (U/L)83.522.961.63.00.070
ALB (g/L)38.30.938.90.30.485
PT (s)13.20.413.50.10.360
AFP (ng/mL)5770.72424.04071.21022.50.622

HCC: hepatocellular carcinoma; SE: standard error; HBV: hepatitis B virus; HCV: hepatitis C virus; AFP: alpha-fetoprotein; TBIL: total bilirubin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALB: albumin; PT: prothrombin time.
The bold value means “ ” or “statistically different”.